Text Size
1 study found for:    NCT01142401

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Recruiting Fulvestrant With or Without Bortezomib in Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer
Conditions: Estrogen Receptor-positive Breast Cancer;   Stage III Breast Cancer;   Stage IIIB Breast Cancer;   Stage IIIC Breast Cancer;   Stage IV Breast Cancer
Interventions: Drug: fulvestrant;   Drug: bortezomib;   Other: laboratory biomarker analysis
To Top

† Indicates status has not been verified in more than two years